A model to infer the pathogenic significance of CDH1 germline missense variants

被引:0
|
作者
Gianpaolo Suriano
Susana Seixas
Jorge Rocha
Raquel Seruca
机构
[1] University of Porto (IPATIMUP),Institute of Molecular Pathology and Immunology
[2] University of Porto,Faculty of Medicine
[3] University of Porto,Faculty of Science
来源
Journal of Molecular Medicine | 2006年 / 84卷
关键词
Hereditary diffuse gastric cancer (HDGC); E-cadherin; Missense mutations; Germline; Co-segregation; In vitro;
D O I
暂无
中图分类号
学科分类号
摘要
Germline mutations of the E-cadherin gene (CDH1) are involved in the tumorigenesis of hereditary diffuse gastric cancer (HDGC). Recent studies have highlighted the lifesaving potential of total prophylactic gastrectomy for CDH1 germline mutation carriers. In this regard, CDH1 germline mutations of the missense type represent a clinical burden in genetic counseling, as their pathogenic relevance is not straightforward. In this work, we have outlined a possible multivariate approach to infer the significance of such variants. We reviewed all HDGC-associated E-cadherin germline missense mutations reported to date. The information collected included: co-segregation of the mutation within pedigrees, frequency in healthy population control, recurrence in independent families, and functional in vitro and in silico data. We used the neighbor-joining method to group mutations according to the collected information and assessed the robustness of mutation clusters with a bootstrap test. CDH1 germline missense variants were classified according to the parameters defined in the multivariate analysis. This analysis allowed the distribution of the variants into two distinct groups: neutral variants vs mutations. The model described in this study provides an important tool that can ultimately improve the genetic counseling offered to the carriers of the germline CDH1 missense variants.
引用
收藏
页码:1023 / 1031
页数:8
相关论文
共 50 条
  • [31] FACTORS PREDICTIVE OF ENDOSCOPIC DETECTION OF SIGNET RING CELLS IN PATIENTS WITH PATHOGENIC AND LIKELY PATHOGENIC CDH1 VARIANTS
    Passi, Monica
    Gamble, Lauren A.
    Schueler, Samuel A.
    Curtin, Bryan
    Gurram, Sandeep
    Quezado, Martha
    Miettinen, Markku
    Heller, Theo
    Koh, Christopher
    Davis, Jeremy L.
    GASTROENTEROLOGY, 2021, 160 (06) : S606 - S606
  • [32] Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria
    Xicola, Rosa M.
    Li, Shuwei
    Rodriguez, Nicolette
    Reinecke, Patrick
    Karam, Rachid
    Speare, Virginia
    Black, Mary Helen
    LaDuca, Holly
    Llor, Xavier
    JOURNAL OF MEDICAL GENETICS, 2019, 56 (12) : 838 - 843
  • [33] Germline CDH1 mutations in bilateral lobular carcinoma in situ
    Petridis, C.
    Shinomiya, I.
    Kohut, K.
    Gorman, P.
    Caneppele, M.
    Shah, V.
    Troy, M.
    Pinder, S. E.
    Hanby, A.
    Tomlinson, I.
    Trembath, R. C.
    Roylance, R.
    Simpson, M. A.
    Sawyer, E. J.
    BRITISH JOURNAL OF CANCER, 2014, 110 (04) : 1053 - 1057
  • [34] Decision-making and regret in patients with germline CDH1 variants undergoing prophylactic total gastrectomy
    Gamble, Lauren A.
    Grant, Robert R. C.
    Samaranayake, Sarah G.
    Fasaye, Grace-Ann
    Koh, Christopher
    Korman, Louis
    Asif, Bilal
    Heller, Theo
    Hernandez, Jonathan M.
    Blakely, Andrew M.
    Davis, Jeremy L.
    JOURNAL OF MEDICAL GENETICS, 2023, 60 (03) : 241 - 246
  • [35] Prophylactic total gastrectomy for individuals with germline CDH1 mutation
    Pandalai, Prakash K.
    Lauwers, Greg Y.
    Chung, Daniel C.
    Patel, Devanshi
    Yoon, Sam S.
    SURGERY, 2011, 149 (03) : 347 - 355
  • [36] IMPACT OF ENDOSCOPIC SURVEILLANCE IN PATIENTS WITH CDH1 GERMLINE MUTATIONS
    Burke, Carol A.
    Cruise, Michael W.
    O'Malley, Margaret
    Mankaney, Gautam N.
    Kalady, Matthew
    Church, James M.
    LaGuardia, Lisa A.
    Heald, Brandie
    GASTROINTESTINAL ENDOSCOPY, 2019, 89 (06) : AB501 - AB501
  • [37] Germline CDH1 mutations in bilateral lobular carcinoma in situ
    C Petridis
    I Shinomiya
    K Kohut
    P Gorman
    M Caneppele
    V Shah
    M Troy
    S E Pinder
    A Hanby
    I Tomlinson
    R C Trembath
    R Roylance
    M A Simpson
    E J Sawyer
    British Journal of Cancer, 2014, 110 : 1053 - 1057
  • [38] CDH1 germline mutations and hereditary lobular breast cancer
    Corso, Giovanni
    Intra, Mattia
    Trentin, Chiara
    Veronesi, Paolo
    Galimberti, Viviana
    FAMILIAL CANCER, 2016, 15 (02) : 215 - 219
  • [39] Clinical spectrum and pleiotropic nature of CDH1 germline mutations
    Figueiredo, Joana
    Melo, Soraia
    Carneiro, Patricia
    Moreira, Ana Margarida
    Fernandes, Maria Sofia
    Ribeiro, Ana Sofia
    Guilford, Parry
    Paredes, Joana
    Seruca, Raquel
    JOURNAL OF MEDICAL GENETICS, 2019, 56 (04) : 199 - 208
  • [40] Germline likely pathogenic variants in ataxia-telangiectasia-mutated gene in an Iranian family with hereditary diffuse gastric cancer without CDH1 mutation
    Kheirollahi, Majid
    Saneipour, Maryam
    Moridnia, Abbas
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (06) : 1434 - 1437